{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/otitis-media-acute/how-up-to-date-is-this-topic/update/","result":{"pageContext":{"chapter":{"id":"7bc4152c-a9f8-5afe-bb63-2a48a86ebf0d","slug":"update","fullItemName":"Update","depth":2,"htmlHeader":"<!-- begin field 133899df-ba5c-4531-8aca-8d684a3add90 --><h2>Update</h2><!-- end field 133899df-ba5c-4531-8aca-8d684a3add90 -->","summary":null,"htmlStringContent":"<!-- begin item 3cbbdcb4-e900-4f21-9bc5-9a86cffe71ec --><!-- end item 3cbbdcb4-e900-4f21-9bc5-9a86cffe71ec -->","topic":{"id":"0671aacb-4e00-5bb2-8b54-aa0da27fb4ab","topicId":"009f13e7-d649-401b-8b63-061c029e67f2","topicName":"Otitis media - acute","slug":"otitis-media-acute","lastRevised":"Last revised in January 2021","chapters":[{"id":"793c7288-db92-5c67-8ef6-0ea9a20f6b09","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"0cbb536b-178c-5bea-a1c6-22c584a7e1b6","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"944570b9-0a8f-5b67-8ee8-556c3fd8a613","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"aedad1bf-9c58-57d9-9c3d-d1fa6e40ee13","slug":"changes","fullItemName":"Changes"},{"id":"7bc4152c-a9f8-5afe-bb63-2a48a86ebf0d","slug":"update","fullItemName":"Update"}]},{"id":"cd84410b-569d-58a4-8fe8-c2eaed2ead26","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"7875d022-7cbf-5961-a19e-d5987af92edc","slug":"goals","fullItemName":"Goals"},{"id":"8db5ac64-8db5-5daa-aa3c-d46caaf0abf3","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"3517d1cc-7aae-5036-81f5-ac0b590e84fd","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"4ca0ace8-77fc-5319-95e0-e983fa092ed9","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"f87cf2b3-b0ea-5485-b424-9518a3f586a2","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"e285c16b-d4ba-56b6-a3fd-3c27fc822357","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"749e39ba-56ce-5129-8e10-fef140b586c2","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"9df3117d-949e-56bb-ac40-0393fb87071a","slug":"definition","fullItemName":"Definition"},{"id":"cb42b641-fdc3-5bd6-a13a-ca2c1edd9c21","slug":"causes","fullItemName":"Causes"},{"id":"2682b3f3-3099-54c9-9c02-867b7f3350e0","slug":"prevalence","fullItemName":"Prevalence"},{"id":"a7d4a184-6baa-5ae6-baef-11eba15038e6","slug":"risk-factors","fullItemName":"Risk factors"},{"id":"fc412f0f-261f-5fae-a125-cfeefdd5e8b3","slug":"prognosis","fullItemName":"Prognosis"},{"id":"18e296ab-cfe3-58be-bf23-aaf4a6c6f49e","slug":"complications","fullItemName":"Complications"}]},{"id":"a0da1ac3-73ef-561b-9301-a1ccdf5fd8a8","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"9e9b0e14-9f7d-5c5a-83a1-c4bfd193ba3d","slug":"diagnosis","fullItemName":"Diagnosis"},{"id":"7e76e099-c70a-5f57-b670-c0ad43913066","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"}]},{"id":"0dac3638-3899-5899-bd0e-647894c3f003","fullItemName":"Management","slug":"management","subChapters":[{"id":"35db78a7-148c-5b20-8fd7-54ea5aaba599","slug":"acute-otitis-media-initial-presentation","fullItemName":"Scenario: Acute otitis media - initial presentation"},{"id":"4d27de1d-1fe0-5438-98c0-f85415825ca5","slug":"persistent-acute-otitis-media-treatment-failure","fullItemName":"Scenario: Persistent acute otitis media - treatment failure"},{"id":"7d848f0c-bb0a-5ea7-90f2-dd99a1cbc49e","slug":"recurrent-acute-otitis-media","fullItemName":"Scenario: Recurrent acute otitis media"}]},{"id":"c8285b67-3320-54ae-8537-4c0626e3632e","fullItemName":"Prescribing information","slug":"prescribing-information","subChapters":[{"id":"f512abb6-f15e-5fef-9f9d-23e008c401ff","slug":"analgesia","fullItemName":"Analgesia"},{"id":"15d20ee0-531c-5230-9e41-6194bfbe3614","slug":"amoxicillin","fullItemName":"Amoxicillin"},{"id":"859385d7-8fde-5b5e-8357-c34d3500eeb7","slug":"clarithromycin","fullItemName":"Clarithromycin"},{"id":"bb1b0220-4609-5ab7-8102-e31414c36dab","slug":"co-amoxiclav","fullItemName":"Co-amoxiclav"},{"id":"0f55a4d8-b11d-53a6-a26e-b2a9e98e8dd8","slug":"erythromycin","fullItemName":"Erythromycin"}]},{"id":"f43bc1b4-a67e-5bab-b27c-d141e7483b01","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"51596c5b-15a7-547d-bdcf-f7a467961cd7","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"f91fb8f9-4942-5683-8b3d-d8edd775f700","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"c2fdf612-fff8-581e-bf78-7c9efcf08ddf","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"2bb0e3c7-8948-5401-97a7-741ffa1d4477","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"570abb9c-faad-515e-86bb-0b947414dcb9","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"5e5c540f-ce64-5768-9c46-dfde85f5364a","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"7f9af8df-6314-54fa-a769-b5bd0bd121ab","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"944570b9-0a8f-5b67-8ee8-556c3fd8a613","slug":"how-up-to-date-is-this-topic","fullItemName":"How up-to-date is this topic?"},"subChapters":[{"id":"70f8bc84-756d-5a0a-a1b9-39c72d8f64be","slug":"new-evidence","fullItemName":"New evidence","depth":3,"htmlHeader":"<!-- begin field f67ac4e3-5179-4587-8825-1577d8d73c7c --><h3>New evidence</h3><!-- end field f67ac4e3-5179-4587-8825-1577d8d73c7c -->","summary":null,"htmlStringContent":"<!-- begin item 7c5de975-6263-42fb-afc4-566b8794a988 --><!-- begin field 507e9cc8-f28e-43d3-8a2b-4378461e5b41 --><h3>Evidence-based guidelines</h3><!-- end field 507e9cc8-f28e-43d3-8a2b-4378461e5b41 --><!-- begin field 27140c72-3d0b-4a38-9d0b-57599d708608 --><p>No new evidence-based guidelines published since 1 May 2018.</p><!-- end field 27140c72-3d0b-4a38-9d0b-57599d708608 --><!-- begin field 713b0d7b-610e-4623-9c46-0fe99531be56 --><h3>HTAs (Health Technology Assessments)</h3><!-- end field 713b0d7b-610e-4623-9c46-0fe99531be56 --><!-- begin field 42a6b51f-dddd-4bf9-be9c-562433c1c350 --><p>No new HTAs since 1 May 2018.</p><!-- end field 42a6b51f-dddd-4bf9-be9c-562433c1c350 --><!-- begin field 33d15279-29f8-49c2-ba09-4b01bceb1e25 --><h3>Economic appraisals</h3><!-- end field 33d15279-29f8-49c2-ba09-4b01bceb1e25 --><!-- begin field d610e4d9-2788-40ff-bbea-74cb140d5de8 --><p>No new economic appraisals relevant to England since 1 May 2018.</p><!-- end field d610e4d9-2788-40ff-bbea-74cb140d5de8 --><!-- begin field 391dc137-9c87-43e2-a8b1-9427a1925dfb --><h3>Systematic reviews and meta-analyses</h3><!-- end field 391dc137-9c87-43e2-a8b1-9427a1925dfb --><!-- begin field 23f7e589-247f-4722-98e8-f25819bdba88 --><ul><li>Fortanier, A., Venekamp, R., Boonacker, C., et al (2019)Â <em>Pneumococcal conjugate vaccines for preventing acute otitis media in children. </em>The Cochrane Library. <a href=\"https://www.cochranelibrary.com/\" data-hyperlink-id=\"0420c3ba-7963-49fc-8835-aa7300a02dac\">www.cochranelibrary.com</a> [<a href=\"https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD001480.pub5/full\" data-hyperlink-id=\"a63f91bb-4634-4f9a-94cb-aa7300a02dfc\">Free Full-text</a>]</li></ul><!-- end field 23f7e589-247f-4722-98e8-f25819bdba88 --><!-- begin field c8293697-f269-400e-94ff-9bc437daa1ba --><h3>Primary evidence</h3><!-- end field c8293697-f269-400e-94ff-9bc437daa1ba --><!-- begin field 32735d1d-21f5-47e2-b545-875e5f3a894b --><ul><li>Cushen, R., Francis, N.A. (2020) Antibiotic use and serious complications following acute otitis media and acute sinusitis: a retrospective cohort study. British Journal of General Practice. <a href=\"http://www.bjgp.org/\" data-hyperlink-id=\"5ceff26c-43b2-47f8-96c6-abdf00986dcf\">www.bjgp.org</a> [<a href=\"https://bjgp.org/content/early/2020/03/09/bjgp20X708821\" data-hyperlink-id=\"55026e75-7f77-4ab6-9203-abdf00986ea0\">Abstract</a>]</li></ul><!-- end field 32735d1d-21f5-47e2-b545-875e5f3a894b --><!-- end item 7c5de975-6263-42fb-afc4-566b8794a988 -->","subChapters":[]},{"id":"adc5936a-6d3e-5858-9af3-57ac3d7510f4","slug":"new-policies","fullItemName":"New policies","depth":3,"htmlHeader":"<!-- begin field d1dce3c8-5c98-4451-b6ad-f77050a3a55c --><h3>New policies</h3><!-- end field d1dce3c8-5c98-4451-b6ad-f77050a3a55c -->","summary":null,"htmlStringContent":"<!-- begin item 1be30192-f2e7-4bed-9f97-3b8e6be20ed7 --><!-- begin field a89453f6-4ec6-405a-9959-cc19305e6a5b --><p>No new national policies or guidelines since 1 May 2018.</p><!-- end field a89453f6-4ec6-405a-9959-cc19305e6a5b --><!-- end item 1be30192-f2e7-4bed-9f97-3b8e6be20ed7 -->","subChapters":[]},{"id":"b2cd274e-cdfb-5a80-a210-4145ccd1da40","slug":"new-safety-alerts","fullItemName":"New safety alerts","depth":3,"htmlHeader":"<!-- begin field ae23e6a0-2a1b-4bac-a79b-22bcc0552dd7 --><h3>New safety alerts</h3><!-- end field ae23e6a0-2a1b-4bac-a79b-22bcc0552dd7 -->","summary":null,"htmlStringContent":"<!-- begin item 6760c1e1-991f-4f10-ae76-f796e2f87383 --><!-- begin field a743b62a-cb34-4cce-9e2a-d418204f27b7 --><p>No new safety alerts since 1 May 2018.</p><!-- end field a743b62a-cb34-4cce-9e2a-d418204f27b7 --><!-- end item 6760c1e1-991f-4f10-ae76-f796e2f87383 -->","subChapters":[]},{"id":"f555f395-4be2-59cc-a2c7-80b3c96904f9","slug":"changes-in-product-availability","fullItemName":"Changes in product availability","depth":3,"htmlHeader":"<!-- begin field 7967aa6f-6599-4f8d-8a0c-161dc8605446 --><h3>Changes in product availability</h3><!-- end field 7967aa6f-6599-4f8d-8a0c-161dc8605446 -->","summary":null,"htmlStringContent":"<!-- begin item 00ad3e0a-e3b5-41fe-938f-04eda3c0e87d --><!-- begin field c22bc83b-37fd-4221-a062-da07e86f608e --><ul><li>Lidocaine hydrochloride, phenazone 40 mg/10 mg/g ear drops solution is licensed for local symptomatic treatment and relief of pain in acute otitis media of the middle ear without tympanic perforation. See more <a href=\"https://www.medicines.org.uk/emc/product/11888/smpc\" data-hyperlink-id=\"307372ec-d12f-4fae-9747-ac7501025121\">here</a>.</li></ul><!-- end field c22bc83b-37fd-4221-a062-da07e86f608e --><!-- end item 00ad3e0a-e3b5-41fe-938f-04eda3c0e87d -->","subChapters":[]}]}}},"staticQueryHashes":["3666801979"]}